⌘K
Loading ticker…
As of 2026-08-24, CryoPort, Inc. Common Stock (CYRX) has a 3-month relative strength percentile of 77 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 69. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.1%, relative volume 0.84×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
CYRX is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 5.3% / 42.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
CYRX is held by 18 ETFs as of May 2026. Top owner: VTWO at 0.02% weight, $4M notional. Top 3 carry $10M.
Held by 37 ETFs · $51M across latest filings · largest weight 0.76% (QQQS).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.02% | $4M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $4M | — |
| VHTVanguard Health Care ETF | 0.01% | $2M | — |
| AVSC | 0.06% | $2M | +0.02 pp |
| VFMO | 0.07% | $1M | +0.02 pp |
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.07% |
| $654K |
| +0.03 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $575K | — |
| VTWV | 0.04% | $477K | +0.02 pp |
| VTWG | 0.01% | $164K | — |
| QQQS | 0.76% | $144K | +0.35 pp |
Showing 10 of 18 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CYRX Jan avg: 5.31% median: -2.01% win: 25% σ: 17.66% n: 4 2022-04-12 → 2026-07-31 | CYRX Feb avg: -5.23% median: -8.29% win: 25% σ: 20.04% n: 4 2022-04-12 → 2026-07-31 | CYRX Mar avg: 4.62% median: 4.66% win: 75% σ: 6.27% n: 4 2022-04-12 → 2026-07-31 | CYRX Apr avg: -5.95% median: -8.53% win: 20% σ: 17.97% n: 5 2022-04-12 → 2026-07-31 | CYRX May avg: 4.89% median: 7.71% win: 60% σ: 33.14% n: 5 2022-04-12 → 2026-07-31 | CYRX Jun avg: 1.37% median: 0.06% win: 60% σ: 23.23% n: 5 2022-04-12 → 2026-07-31 | CYRX Jul avg: 8.24% median: -1.74% win: 40% σ: 17.72% n: 5 2022-04-12 → 2026-07-31 | CYRX Aug avg: -0.65% median: -5.62% win: 50% σ: 15.64% n: 4 2022-04-12 → 2026-07-31 (current) | CYRX Sep avg: -8.54% median: -7.87% win: 25% σ: 13.89% n: 4 2022-04-12 → 2026-07-31 | CYRX Oct avg: -8.93% median: -10.21% win: 25% σ: 18.78% n: 4 2022-04-12 → 2026-07-31 | CYRX Nov avg: 6.53% median: 5.21% win: 75% σ: 30.01% n: 4 2022-04-12 → 2026-07-31 | CYRX Dec avg: 2.00% median: 4.84% win: 50% σ: 10.64% n: 4 2022-04-12 → 2026-07-31 |